Inhibition of extracellular HMGB1 in experimental models of myocardial ischemia/reperfusion injury, myocarditis, cardiomyopathy induced by mechanical stress, diabetes, bacterial infection or chemotherapy drugs reduces inflammation and is protective. This evidence concerns the gene HMGB1 and cardiomyopathy.